Non-viral Delivery Systems for Breast Cancer Gene Therapy

Curr Gene Ther. 2017;17(2):147-153. doi: 10.2174/1566523217666170606124131.

Abstract

Introduction: The ever-evolving field of gene therapy promises several innovative treatments for cancer. Advances in genetic modification of tumor cells and micro environment have led to the development of more effective therapeutic strategies with fewer side effects.

Materials & methods: The development of effective delivery system challenges, remains. Non-viral vectors are interesting due to their bio-safety and their ability to transfer different types of nucleic acids. Examples of these techniques are the use of oligonucleoides, liposomes, nanoparticles, inorganic material, and engineered stem cells.

Conclusion: In this review, we focus on recent advances in the intracellular delivery of DNA and siRNA to the cancer cells with emphasis on breast cancer.

Keywords: APTAMER; Breast cancer; DNA; Gene therapy; Non-viral delivery system; RNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Breast Neoplasms / genetics
  • Breast Neoplasms / therapy*
  • Drug Delivery Systems / methods*
  • Gene Transfer Techniques*
  • Genetic Therapy / methods*
  • Humans
  • Nanoparticles / administration & dosage
  • Nanoparticles / chemistry
  • Nucleic Acids / administration & dosage
  • Nucleic Acids / chemistry
  • Nucleic Acids / genetics
  • RNA, Small Interfering / administration & dosage
  • RNA, Small Interfering / chemistry
  • RNA, Small Interfering / genetics
  • Reproducibility of Results

Substances

  • Nucleic Acids
  • RNA, Small Interfering